risperidone has been researched along with Kidney Failure, Chronic in 3 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The hyperprolactinemia was due to prolonged treatment with the anti-dopaminergic neuroleptic risperidone in Case 1, and chronic renal failure in Case 2." | 3.74 | Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia. ( Bruno, R; Calcinaro, F; Colandrea, M; Durante, C; Filetti, S; Maranghi, M; Montesano, T; Puxeddu, E; Ronga, G; Russo, D; Travascio, L, 2007) |
| "A patient with chronic renal failure (CRF) developed neuroleptic malignant syndrome (NMS) after administration of risperidone and levomepromazine." | 3.71 | Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure. ( Fukasawa, T; Hayashi, H; Kawakatsu, S; Otani, K; Watanabe, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, H | 1 |
| Kawakatsu, S | 1 |
| Watanabe, K | 1 |
| Fukasawa, T | 1 |
| Otani, K | 1 |
| Ronga, G | 1 |
| Bruno, R | 1 |
| Puxeddu, E | 1 |
| Calcinaro, F | 1 |
| Montesano, T | 1 |
| Travascio, L | 1 |
| Colandrea, M | 1 |
| Durante, C | 1 |
| Maranghi, M | 1 |
| Filetti, S | 1 |
| Russo, D | 1 |
| Snoeck, E | 1 |
| Van Peer, A | 1 |
| Sack, M | 1 |
| Horton, M | 1 |
| Mannens, G | 1 |
| Woestenborghs, R | 1 |
| Meibach, R | 1 |
| Heykants, J | 1 |
1 trial available for risperidone and Kidney Failure, Chronic
| Article | Year |
|---|---|
Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Blood Proteins; Female; Half-Life; Humans; Kidney Fa | 1995 |
2 other studies available for risperidone and Kidney Failure, Chronic
| Article | Year |
|---|---|
Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure.
Topics: Adult; Antipsychotic Agents; Gastrointestinal Hemorrhage; Glomerulonephritis; Humans; Kidney Failure | 2002 |
Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia.
Topics: Breast; Carcinoma, Papillary; Female; Humans; Hyperprolactinemia; Iodine Radioisotopes; Kidney Failu | 2007 |